SURF BIO

HQ - Palo Alto

Summary

Surf Bio develops therapeutic solutions for diabetes, oncology, infectious diseases, and gene therapy.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 291 M

Avg. Deal Size£ 291 M

Market Context